Hong J H, Sumrani N, Delaney V, Davis R, Dibenedetto A, Butt K M
Department of Surgery, State University of New York, Brooklyn 11203.
Nephron. 1992;62(3):272-9. doi: 10.1159/000187058.
A single center experience of 514 ciclosporin-treated renal allografts which survived longer than 1 year was reviewed in order to analyze the causes of renal allograft loss beyond the 1st year post-transplantation and the contribution of selected parameters to long-term survival. 83 grafts were lost between 1 and 5 years with the most common causes of graft loss being chronic rejection (54%), death (14%), noncompliance (13%) and sepsis (11%). Actuarial 5-year graft survival rates, decaying from 100% at 1 year, of living related and cadaveric grafts were 88.6 and 79.5%, respectively. Parameters with a substantial influence on long-term survival included the quality of early graft function and incidence of acute rejection in the 1st year post-transplantation. A marker for long-term survival (> 5 years) was a significantly lower serum creatinine (177 mumol/l; < or = 2 mg/dl) at 1 year. We conclude that chronic rejection is responsible for the majority of late graft losses in the ciclosporin era as in the earlier azathioprine period.
回顾了514例接受环孢素治疗且存活超过1年的肾移植受者的单中心经验,以分析移植后第1年以后肾移植失败的原因以及选定参数对长期存活的影响。83例移植肾在1至5年内失功,移植肾失功的最常见原因是慢性排斥反应(54%)、死亡(14%)、不依从(13%)和败血症(11%)。亲属活体肾移植和尸体肾移植的5年精算移植存活率从1年时的100%开始下降,分别为88.6%和79.5%。对长期存活有重大影响的参数包括移植后第1年早期移植肾功能的质量和急性排斥反应的发生率。长期存活(>5年)的一个标志是1年时血清肌酐显著降低(177μmol/L;≤2mg/dl)。我们得出结论,与早期硫唑嘌呤时代一样,在环孢素时代,慢性排斥反应是大多数晚期移植肾失功的原因。